U.S. Pharmaceuticals & Biotech Buy the Dip

Illumina

Market Cap: US$28.4b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Elanco Animal Health

Market Cap: US$11.1b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Bruker

Market Cap: US$7.8b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.

Tyra Biosciences

Market Cap: US$1.6b

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Faeth Therapeutics

Market Cap: US$631.1m

A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.

Zentalis Pharmaceuticals

Market Cap: US$355.9m

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.

Coherus Oncology

Market Cap: US$196.2m

A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.

Fortress Biotech

Market Cap: US$88.7m

Operates as a biopharmaceutical company in the United States and internationally.

Exousia Bio

Market Cap: US$21.0m

A biotechnology company, designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells.